Procyanidins inhibit tumor angiogenesis by crosslinking extracellular matrix

Chinese Journal of Cancer Research

Volumn 23, Issue 2, 2011, Pages 99-106

  Zhai, Wan Yin ^a,b,c   Jia, Chun Ping ^a   Zhao, Hui ^a   Xu, Yuan Sen ^a  

^a SHANGHAI INSTITUTE OF MICROSYSTEM AND INFORMATION TECHNOLOGY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

Angiogenesis; Crosslinking; Extracellular matrix; Matrix metalloproteinases; Procyanidins

Indexed keywords

GELATINASE A; IRINOTECAN; PROCYANIDIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; PROTEIN CROSS LINKING; PROTEIN DEGRADATION; RAT; TUMOR VOLUME; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 80051623373     PISSN: 10009604     EISSN: 19930631     Source Type: Journal    
DOI: 10.1007/s11670-011-0099-y     Document Type: Article

References (38)

1. Kessenbrock K, Plaks V, Werb Z. Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell 2010; 141: 52-67.
2. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-39. (Pubitemid 36542523)
3. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 2002; 90: 251-62. (Pubitemid 34633925)
4. Oak MH, EI Bedoui J, Schini-Kerth VB. Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutri Bioch 2005; 16:1-8. (Pubitemid 40052710)
5. Nandakumar V, Singh T, Katiyar SK. Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 2008; 269: 378-87.
6. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 2000; 10: 415-33. (Pubitemid 32181912)
7. Coussens LM, Fingleton B, Matrisian LM. Matrix Metalloproteinase Inhibitors and Cancer: Trials and Tribulations. Science 2002; 295: 2387-92. (Pubitemid 34270240)
8. Yamakoshi J, Saito M, Kataoka S, et al. Safety evaluation of proanthocyanidins-rich extract from grape seeds. Food Chem Toxicol 2002; 40: 599-607. (Pubitemid 34310425)
9. Packer L, Rimbach G, Virgili F. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus Maritima) bark, pycnogenol. Free Radic Biol Med 1999; 27: 704-24. (Pubitemid 29408657)
10. Gonther MP, Donovan JL, Texier O, et al. Metabolism of dietary procyanidins in rats. Free Radic Boil Med 2003; 35: 837-44. (Pubitemid 37211438)
11. Urpi-Sarda M, Monagas M, Khan N, et al. Epicatechin, procyanidins, and phenolic microbial metabolisms after cocoa intake in humans and rats. Anal Bioanal Chem 2009; 394: 1545-56.
12. Mantena SK, Baliga MS, Katiyar SK. Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis 2006; 27: 1682-91. (Pubitemid 44288058)
13. Singh RP, Tyagi AK, Dhanalakshmi S, et al. Grape seed extract inhibits advanced human prostate tumor growth and angiogenesis and up-regulates insulin-like growth factor binding protein-3. Int J Cancer 2004; 108: 733-40. (Pubitemid 38076405)
14. Mittal A, Elmets CA, Katiyar SK. Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 2003; 24: 1379-88. (Pubitemid 37038827)
15. Oak MH, EI Bedoui J, Anglard P, et al. Red wine polyphenolic compounds strongly inhibit pro-MMP-2 expression and its activation in response to thrombin via direct inhibition of MT1-MMP in vascular smooth muscle cells. Circulation 2004; 110:1861-7. (Pubitemid 39299230)
16. Strek M, Gorlach S, Podsedek A, et al. Procyanidin oligomers from Japanese quince (Chaenomeles japonica) fruit inhibit activity of MMP-2 and MMP-9 metalloproteinases. J Agric Food Chem 2007; 55: 6447-52. (Pubitemid 47287439)
17. Vayalil PK, Mittal A, Katiyar SK. Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells which is associated with the inhibition of activation of MAPK and NFkB. Carcinogenesis 2004; 25: 987-95.
18. Agarwal C, Singh RP, Dhanalakshmi S, et al. Anti-angiogenic efficacy of grape seed extract in endothelial cells. Oncol Rep 2004; 11: 681-5.
19. Meeran SM, Katiyar SK. Proanthocyanidins inhibit mitogenic and survival-signaling in vitro and tumor growth in vivo. Front Biosci 2008; 13: 887-97. (Pubitemid 351594734)
20. Nassiri-Asl M, Hosseinzadeh H. Review of the pharmacological effects of vitis vinifera (Grape) and its bioactive compounds. Phytother Res 2009; 23:1197-204.
21. Han B, Jaurequi J, Tang WB, Nimni ME. Proanthocyanidin: a natural crosslinking reagent for stabilizing collagen matrix. J Biomed Mater Res 2003; 65A:118-24. (Pubitemid 37517292)
22. Hagerman AE, Butler LG. The specificity of proanthocyanidinprotein interactions. J Biol Chem 1981; 256: 4494-7.
23. Zhai W, Chang J, Lin K, et al. Crosslinking of decellularized porcine heart valve matrix by procyanidins. Biomaterials 2006; 27: 3684-90.
24. Cheung DT, Tong D, Perelman N, et al. Mechanism of crosslinking of proteins by glutaraldehyde. IV: In vitro and in vivo stability of a crosslinked collagen matrix. Connect Tissue Res 1990; 25: 27-34.
25. Heinke J, Wehofsits L, Zhou Q, et al. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis. Circ Res 2008; 103: 804-12.
26. Day RM, Boccaccini AR, Shurey S, et al. Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials 2004; 25: 5857-66. (Pubitemid 38684182)
27. Fischer C, Jonckx B, Mazzone M, et al. Anti-PlGF inhibits growthof VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 2007; 131: 463-75. (Pubitemid 350007692)
28. Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin 2010; 60: 222-43.
29. Gingras D, Bousquet-Gagnon N, Langois S, et al. Activation of the extracellular signal regulated signal-regulated protein kinase (ERK) cascade by membrane type-1matrix metalloproteinase (MT1-MMP). FEBS Lett 2001; 507: 231-6.
30. Kiran MS, Sameer-Kumar VB, Viji RI, et al. Temporal relationship between MMP production and angiogenic process in HUVECs. Cell Biol Int 2006; 30: 704-13. (Pubitemid 44331628)
31. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999; 13: 35-48. (Pubitemid 29045114)
32. Levental KR, Yu H, Kass L, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139: 891-906.
33. Shahat AA, Cos P, De Bruyne T, et al. Antiviral and antioxidation activity of flavonoids and proanthocyanidins from Crataegus sinaica. Planta Med 2002; 68: 539-41. (Pubitemid 34774751)
34. Nakane H, Ono K. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficienct virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerase. Biochemistry 1990; 29: 2841-5. (Pubitemid 20122620)
35. Austin CA, Patel S, Ono K, et al. Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochem J 1992; 282: 883-9.
36. Slusarewicz P, Zhu K, Hedman T. Kinetic characterization and comparison of various protein crosslinking reagents for matrix modification. J Mater Sci Mater Med 2010; 21: 1175-81.
37. Punathil T and Katiyar SK. Inhibition of Non-small Cell Lung Cancer Cell Migration by Grape Seed Proanthocyanidins Is Mediated Through the Inhibition of Nitric Oxide, Guanylate Cyclase, and ERK1/2. Mol Carcinog 2009; 48: 232-42.
38. Akhtars, Meeran SM, Katiyar N, et al. Grape seed proanthocyanidins inhibit the growth of human non-small cell lung cancer xenografts by targeting insulin-like growth factor binding protein-3, tumor cell proliferation, and angiogenic factors. Clin Cancer Res 2009; 15: 821-31.